Metabolic disorders in patients with psoriasis and psoriatic arthritis.
about
Psoriasis, non-alcoholic fatty liver disease, and cardiovascular disease: Three different diseases on a unique backgroundMaking the next steps in psoriatic arthritis management: current status and future directionsReview of the treatment of psoriatic arthritis with biological agents: choice of drug for initial therapy and switch therapy for non-responders.Psoriasis and the risk of diabetes and hypertension: a prospective study of US female nurses.Clinico-biochemical correlation between psoriasis and insulin resistanceA study of awareness and screening behavior of cardiovascular risk factors in patients with psoriasis and dermatologistsStudy on the use of omega-3 fatty acids as a therapeutic supplement in treatment of psoriasis.Non-alcoholic fatty liver disease and psoriasis: So far, so near.Psoriasis and increased prevalence of hypertension and diabetes mellitus.Analysis of cardiovascular risk factors and metabolic syndrome in korean patients with psoriasis.Associations between cardiovascular risk factors and psoriasis in Iran.Prevalence of metabolic syndrome in South Indian patients with psoriasis vulgaris and the relation between disease severity and metabolic syndrome: a hospital-based case-control study.Obesity and the risk of psoriatic arthritis: a population-based study.Moderate and severe plaque psoriasis: cost-of-illness study in Italy.Extrahepatic Manifestations of Nonalcoholic Fatty Liver DiseasePsoriatic arthritis and diabetes: a population-based cross-sectional studyPsoriasis comorbidities.The association between body mass index and arthritis among US adults: CDC's surveillance case definition.Smoking and the risk of psoriasis in women: Nurses' Health Study II.Treatment recommendations for psoriatic arthritis.Metabolic Syndrome in Psoriasis among Urban South Indians: A Case Control Study Using SAM-NCEP Criteria.Emerging drugs for psoriatic arthritis.Etanercept provides an effective, safe and flexible short- and long-term treatment regimen for moderate-to-severe psoriasis: a systematic review of current evidence.Managing moderate-to-severe psoriasis in the elderly.Advances in the management of psoriatic arthritis.Comparative Effectiveness of Adalimumab versus Secukinumab for the Treatment of Psoriatic Arthritis: A Matching-Adjusted Indirect Comparison.Apremilast in the treatment of psoriatic arthritis: a perspective review.Increased serum C-reactive protein level in Japanese patients of psoriasis with cardio- and cerebrovascular disease.Metabolic syndrome in Tunisian psoriatic patients: prevalence and determinants.Liver Stiffness Measurement in Psoriasis: Do Metabolic or Disease Factors Play the Important Role?High prevalence of metabolic syndrome in patients with psoriasis in Lebanon: a prospective study.Serum levels of adipocytokines in psoriasis patients receiving tumor necrosis factor-α inhibitors: results of a retrospective analysis.Prevalence of Metabolic Syndrome in Patients with Mucosal Lichen Planus: A Case-Control Study.Safety and efficacy of calcium folinate in psoriasis: an observational study.Update in treatment options for psoriatic arthritis.Cardiovascular disease and risk factors among psoriasis patients in two US healthcare databases, 2001-2002.Associated comorbidities in psoriasis and inflammatory bowel disease.Metabolic syndrome in psoriatic arthritis patients: a cross-sectional study.Prevalence of metabolic syndrome in patients with psoriasis.
P2860
Q26765175-4F0138DA-8F11-41A5-A449-CB5663C95F21Q26783506-796C2AAD-CAF3-4433-A36C-7DB932359661Q30399745-FA93E331-B813-4B6C-9F7E-ED2F49949C0DQ33767803-50C58C80-DBC5-4D14-9027-A26C1C58A209Q35028089-A2131831-65EF-44BD-96E2-A2B417D2DDFDQ35069963-C6752F2D-5BD5-45B4-AA77-1AE24FD55365Q35096973-BB90688E-A177-47F2-AE6F-F293D45670ACQ35237307-491D349E-F406-4900-876B-0E17C429D378Q35564637-92324DD4-DD8E-49C0-86A6-B3B3FA41AE45Q35770123-DECEC82B-C447-4361-B56F-5A87057EEF11Q35954321-283E25C9-EC4A-4963-B296-248CD36F4459Q36352320-4A428C2A-9A0F-4A79-BAE3-64312E0EE156Q36820863-90AE7A60-BC5B-4070-8C4B-D2066FC23944Q36823606-EF5E746B-7803-4851-B783-4222C8D4A437Q36921610-0E636ABF-EDE2-44B5-8CDA-F540072FE1B6Q36988417-401E55F0-1F66-4B5A-9D83-35BC2CDA4D6DQ37084274-68D88F6F-0907-4B1A-8C30-E5FAF4553B2AQ37206092-A0752DDE-2CE1-431D-B848-5DAED5CDE5AFQ37227428-04A5A6C4-B9CE-42F3-BD52-65DE31B27E29Q37284516-3BBAD6E5-7612-49F0-A859-E28E0D19C7C4Q37734265-3E6B956D-68F5-417F-9E03-CCD7BE9030E5Q37763192-DB70537E-2EE0-415C-9016-D33482A0B945Q38027577-4E24ECBB-03F3-44EA-BC34-DB7DADBCAD9FQ38189734-43D55AA9-5E33-47DC-A262-A3F476DBF944Q38227264-3013BAB6-3B9E-483F-9B32-60F4A30C8B3BQ38648826-2E36A44A-438F-45A1-9813-E913353BF5DAQ38932094-737ED98B-8234-4138-8BF1-9E0DA4241B2AQ39117416-FC2FCD44-D49C-466B-B43C-1FD03C065A0CQ39238988-93F9114E-07DF-4926-8F5D-5339E53FDDA6Q40837256-3C0AF4BB-F023-4336-A4A3-B53CC50B09FBQ40988865-36F50D06-6FEB-4E17-8D0D-38B31010B6B9Q41068916-0A78D3E0-80C4-47A4-A364-14CB7FD79817Q41582154-13E8512E-3D20-4C1C-88F6-1CA2D0F61962Q42964135-988478A8-5828-4B7E-8A55-252096F1B959Q43061552-55B68AD9-368C-4A82-A950-9C02DA728593Q44859412-8F31634A-C3AA-4E7C-9A86-F09A0E59964FQ45907246-A7214C6C-775C-4FB8-A407-B42BCC2957C0Q51329205-0CD9EF7F-B643-4638-BA3F-28C7B410D510Q51356145-9545FF8E-F086-4C30-BD74-45E9DB7B1EBE
P2860
Metabolic disorders in patients with psoriasis and psoriatic arthritis.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Metabolic disorders in patients with psoriasis and psoriatic arthritis.
@ast
Metabolic disorders in patients with psoriasis and psoriatic arthritis.
@en
type
label
Metabolic disorders in patients with psoriasis and psoriatic arthritis.
@ast
Metabolic disorders in patients with psoriasis and psoriatic arthritis.
@en
prefLabel
Metabolic disorders in patients with psoriasis and psoriatic arthritis.
@ast
Metabolic disorders in patients with psoriasis and psoriatic arthritis.
@en
P1476
Metabolic disorders in patients with psoriasis and psoriatic arthritis.
@en
P2093
Christopher T Ritchlin
Lotus Mallbris
P2860
P2888
P304
P356
10.1007/S11926-006-0065-8
P577
2006-10-01T00:00:00Z